Yellowstone Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-12,860
Closed -$861K 188
2017
Q3
$861K Buy
+12,860
New +$909K 0.45% 56
2016
Q3
$1.92M Sell
24,712
-470
-2% -$38K 0.71% 29
2016
Q2
$1.96M Buy
25,182
+43
+0.2% +$3.43K 0.84% 25
2016
Q1
$2.06M Buy
25,139
+1,068
+4% +$86.8K 0.89% 24
2015
Q4
$2.15M Buy
24,071
+3,879
+19% +$329K 0.97% 20
2015
Q3
$1.55M Buy
20,192
+4,415
+28% +$369K 0.73% 28
2015
Q2
$1.32M Sell
15,777
-726
-4% -$64.1K 0.6% 35
2015
Q1
$1.49M Buy
16,503
+1,270
+8% +$109K 0.75% 33
2014
Q4
$1.23M Buy
15,233
+283
+2% +$22.3K 0.66% 36
2014
Q3
$1.12M Sell
14,950
-557
-4% -$40.5K 0.63% 38
2014
Q2
$1.06M Sell
15,507
-1,091
-7% -$74.3K 0.62% 36
2014
Q1
$1.16M Sell
16,598
-557
-3% -$38.7K 0.73% 25
2013
Q4
$1.15M Buy
+17,155
New +$1.05M 0.74% 28

Other funds holding CAH

Yellowstone Partners's CAH Position: Q4 2017 in Review

Yellowstone Partners sold out of Cardinal Health (CAH) in Q4 2017, closing a stake of 12,860 shares — an estimated $861K sold.

Yellowstone Partners first reported a position in CAH in Q4 2013 and held it in 13 quarters. The position peaked at $2.15M in Q4 2015. 722 funds tracked by Wall St. Rank hold CAH as of Q4 2017.

  • Yellowstone Partners reported no remaining Cardinal Health position as of Q4 2017 after selling out during the quarter.
  • Yellowstone Partners sold 12,860 Cardinal Health shares in Q4 2017, an estimated $861K.
  • Yellowstone Partners first reported a position in Cardinal Health in Q4 2013 and held it in 13 quarters.
  • Yellowstone Partners's Cardinal Health position peaked at $2.15M in Q4 2015.
  • 722 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2017.

Based on Yellowstone Partners's 13F filing for Q4 2017, filed 24 Jan 2018.